[How to choose among 3 treatment options in the care of end stage renal disease: special emphasis on kidney transplantation].
Shibagaki
Yugo
Y
D000367:Age Factors; D001788:Blood Grouping and Crossmatching; D002318:Cardiovascular Diseases / Q000209:etiology / Q000628:therapy; D003362:Cost-Benefit Analysis; D006648:Histocompatibility; D006801:Humans; D007166:Immunosuppressive Agents; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D016030:Kidney Transplantation / Q000191:economics / Q000639:trends; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011379:Prognosis; D011788:Quality of Life; D006435:Renal Dialysis; D012306:Risk; D014019:Tissue Donors
D007166:Immunosuppressive Agents